172 related articles for article (PubMed ID: 15144579)
21. Herpes simplex virus type 1 (HSV-1)-derived amplicon vectors.
Melendez ME; Fraefel C; Epstein AL
Methods Mol Biol; 2014; 1144():81-98. PubMed ID: 24671678
[TBL] [Abstract][Full Text] [Related]
22. Herpes simplex virus type-1 amplicon vectors for vaccine generation in acute lymphoblastic leukemia.
Zibert A; Thomassen A; Müller L; Nguyen L; Glouchkova L; Fraefel C; Roskrow M; Meisel R; Dilloo D
Gene Ther; 2005 Dec; 12(23):1707-17. PubMed ID: 16034459
[TBL] [Abstract][Full Text] [Related]
23. Herpes simplex virus type 1 amplicon vector-mediated gene transfer to muscle.
Wang Y; Mukherjee S; Fraefel C; Breakefield XO; Allen PD
Hum Gene Ther; 2002 Jan; 13(2):261-73. PubMed ID: 11812282
[TBL] [Abstract][Full Text] [Related]
24. Imaging herpes simplex virus type 1 amplicon vector-mediated gene expression in human glioma spheroids.
Kaestle C; Winkeler A; Richter R; Sauer H; Hescheler J; Fraefel C; Wartenberg M; Jacobs AH
Mol Imaging; 2011 Jun; 10(3):197-205. PubMed ID: 21443839
[TBL] [Abstract][Full Text] [Related]
25. FasL and FADD delivery by a glioma-specific and cell cycle-dependent HSV-1 amplicon virus enhanced apoptosis in primary human brain tumors.
Ho IA; Ng WH; Lam PY
Mol Cancer; 2010 Oct; 9():270. PubMed ID: 20942909
[TBL] [Abstract][Full Text] [Related]
26. Optimization of adenoviral vector-mediated transgene expression in the canine brain in vivo, and in canine glioma cells in vitro.
Candolfi M; Pluhar GE; Kroeger K; Puntel M; Curtin J; Barcia C; Muhammad AK; Xiong W; Liu C; Mondkar S; Kuoy W; Kang T; McNeil EA; Freese AB; Ohlfest JR; Moore P; Palmer D; Ng P; Young JD; Lowenstein PR; Castro MG
Neuro Oncol; 2007 Jul; 9(3):245-58. PubMed ID: 17522335
[TBL] [Abstract][Full Text] [Related]
27. Optimal purification method for Herpes-based viral vectors that confers minimal cytotoxicity for systemic route of vector administration.
Sia KC; Wang GY; Ho IA; Khor HY; Miao L; Hui KM; Lam PY
J Virol Methods; 2007 Feb; 139(2):166-74. PubMed ID: 17074404
[TBL] [Abstract][Full Text] [Related]
28. Extending the transposable payload limit of Sleeping Beauty (SB) using the Herpes Simplex Virus (HSV)/SB amplicon-vector platform.
de Silva S; Mastrangelo MA; Lotta LT; Burris CA; Federoff HJ; Bowers WJ
Gene Ther; 2010 Mar; 17(3):424-31. PubMed ID: 19865178
[TBL] [Abstract][Full Text] [Related]
29. Tumour-specific triple-regulated oncolytic herpes virus to target glioma.
Delwar ZM; Liu G; Kuo Y; Lee C; Bu L; Rennie PS; Jia WW
Oncotarget; 2016 May; 7(19):28658-69. PubMed ID: 27070093
[TBL] [Abstract][Full Text] [Related]
30. Enhanced cytotoxicity with a novel system combining the paclitaxel-2'-ethylcarbonate prodrug and an HSV amplicon with an attenuated replication-competent virus, HF10 as a helper virus.
Ishida D; Nawa A; Tanino T; Goshima F; Luo CH; Iwaki M; Kajiyama H; Shibata K; Yamamoto E; Ino K; Tsurumi T; Nishiyama Y; Kikkawa F
Cancer Lett; 2010 Feb; 288(1):17-27. PubMed ID: 19604626
[TBL] [Abstract][Full Text] [Related]
31. Augmented therapeutic efficacy of an oncolytic herpes simplex virus type 1 mutant expressing ICP34.5 under the transcriptional control of musashi1 promoter in the treatment of malignant glioma.
Kanai R; Tomita H; Hirose Y; Ohba S; Goldman S; Okano H; Kawase T; Yazaki T
Hum Gene Ther; 2007 Jan; 18(1):63-73. PubMed ID: 17238803
[TBL] [Abstract][Full Text] [Related]
32. HSV-1 amplicon viral vector-mediated gene transfer to human bone marrow-derived mesenchymal stem cells.
Ho IA; Chan KY; Miao L; Shim WS; Guo CM; Cheang P; Hui KM; Lam PY
Cancer Gene Ther; 2008 Sep; 15(9):553-62. PubMed ID: 18535622
[TBL] [Abstract][Full Text] [Related]
33. Integration of active human beta-galactosidase gene (100 kb) into genome using HSV/AAV amplicon vector.
Oehmig A; Cortés ML; Perry KF; Sena-Esteves M; Fraefel C; Breakefield XO
Gene Ther; 2007 Jul; 14(14):1078-91. PubMed ID: 17460718
[TBL] [Abstract][Full Text] [Related]
34. Herpes simplex virus type 1 (HSV-1)-derived amplicon vectors for gene transfer and gene therapy.
Fraefel C; Marconi P; Epstein AL
Methods Mol Biol; 2015; 1254():295-316. PubMed ID: 25431073
[TBL] [Abstract][Full Text] [Related]
35. Selective expression of foreign genes in glioma cells: use of the mouse myelin basic protein gene promoter to direct toxic gene expression.
Miyao Y; Shimizu K; Moriuchi S; Yamada M; Nakahira K; Nakajima K; Nakao J; Kuriyama S; Tsujii T; Mikoshiba K
J Neurosci Res; 1993 Nov; 36(4):472-9. PubMed ID: 7505843
[TBL] [Abstract][Full Text] [Related]
36. Engineering cell lines for production of replication defective HSV-1 gene therapy vectors.
Grant KG; Krisky DM; Ataai MM; Glorioso JC
Biotechnol Bioeng; 2009 Mar; 102(4):1087-97. PubMed ID: 18828174
[TBL] [Abstract][Full Text] [Related]
37. Progress and prospects: biological properties and technological advances of herpes simplex virus type 1-based amplicon vectors.
Epstein AL
Gene Ther; 2009 Jun; 16(6):709-15. PubMed ID: 19369969
[TBL] [Abstract][Full Text] [Related]
38. Construction and packaging of herpes simplex virus/adeno-associated virus (HSV/AAV) Hybrid amplicon vectors.
Saydam O; Glauser DL; Fraefel C
Cold Spring Harb Protoc; 2012 Mar; 2012(3):352-6. PubMed ID: 22383640
[TBL] [Abstract][Full Text] [Related]
39. Establishment of a novel foreign gene delivery system combining an HSV amplicon with an attenuated replication-competent virus, HSV-1 HF10.
Zhang L; Daikoku T; Ohtake K; Ohtsuka J; Nawa A; Kudoh A; Iwahori S; Isomura H; Nishiyama Y; Tsurumi T
J Virol Methods; 2006 Nov; 137(2):177-83. PubMed ID: 16854473
[TBL] [Abstract][Full Text] [Related]
40. Gene delivery using herpes simplex virus vectors.
Burton EA; Fink DJ; Glorioso JC
DNA Cell Biol; 2002 Dec; 21(12):915-36. PubMed ID: 12573050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
